CCAP (Crescent Capital BDC) 1-Year Sharpe Ratio: -0.88 (As of Jul. 12, 2026)


CCAP Crescent Capital BDC Inc CCAP
49 GF Score
Price $11.09
GF Value $6.84
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Crescent Capital BDC 1-Year Sharpe Ratio?

Crescent Capital BDC CCAP +1.84% 49 1-Year Sharpe Ratio is -0.88 as of Jul. 12, 2026. GuruFocus rates CCAP with a GF Score™ of 49/100 and a GF Value™ of $6.84 (Significantly Overvalued). The stock has 4 warning signs investors should review.

The 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk over the past year. As of today (2026-07-12), Crescent Capital BDC's 1-Year Sharpe Ratio is -0.88.

Crescent Capital BDC  (NAS:CCAP) 1-Year Sharpe Ratio Explanation

The 1-Year Sharpe Ratio inidicates the risk-adjusted return of an investment over the past year. It is calculated as the annualized result of the average monthly excess return divided by its standard deviation over the past year. The monthly excess return is the monthly investment return minus the monthly risk-free rate (typically the 10-year Treasury Constant Maturity Rate). If the risk-free rate for a specific region is not available, U.S. data is used by default.

The greater a portfolio's Sharpe Ratio, the better its risk-adjusted performance. A negative Sharpe Ratio means the risk-free rate is greater than the portfolio’s historical or projected return, or else the portfolio's return is expected to be negative.

Crescent Capital BDC 1-Year Sharpe Ratio Related Terms

CCAP vs INV, LEO, VKI: 1-Year Sharpe Ratio Comparison

For the Asset Management subindustry, Crescent Capital BDC's 1-Year Sharpe Ratio, along with its competitors' market caps and 1-Year Sharpe Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Crescent Capital BDC 1-Year Sharpe Ratio vs Asset Management Industry

For the Asset Management industry and Financial Services sector, Crescent Capital BDC's 1-Year Sharpe Ratio distribution charts can be found below:

* The bar in red indicates where Crescent Capital BDC's 1-Year Sharpe Ratio falls into.


CCAP
49GF Score
Crescent Capital BDC Inc CCAP
1-Year Sharpe Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Crescent Capital BDC 1-Year Sharpe Ratio Calculation

The 1-Year Sharpe Ratio measures the performance of an investment such as a stock or portfolio compared to a risk-free asset. A stock / portfolio's 1-Year Sharpe Ratio can be calculated by dividing the difference between the one-year returns of the investment and the risk-free rate, by the standard deviation of the investment returns over one year.

Frequently Asked Questions Learn more about 1-Year Sharpe Ratio →
What does a 1-Year Sharpe Ratio of -0.88 mean?
Crescent Capital BDC (CCAP) has a 1-Year Sharpe Ratio of -0.88 as of Jul. 12, 2026. 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk. View historical data for Crescent Capital BDC and its competitors.
Is Crescent Capital BDC's 1-Year Sharpe Ratio too high?
Crescent Capital BDC's current 1-Year Sharpe Ratio is -0.88. Overall, Crescent Capital BDC has a GF Score™ of 49/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Crescent Capital BDC's 1-Year Sharpe Ratio compare to INV and LEO?
Crescent Capital BDC's 1-Year Sharpe Ratio of -0.88 can be compared against companies in the Asset Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 1-Year Sharpe Ratio for an Asset Management company?
A good 1-Year Sharpe Ratio depends on the Asset Management industry context. However, 1-Year Sharpe Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 1-Year Sharpe Ratio mean?
A high 1-Year Sharpe Ratio can signal that a stock is expensive relative to its fundamentals. 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk. View historical data for Crescent Capital BDC and its competitors. Crescent Capital BDC's current 1-Year Sharpe Ratio is -0.88. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Crescent Capital BDC stock overvalued right now?
Based on GuruFocus' analysis, Crescent Capital BDC (CCAP) is currently considered Significantly Overvalued. The stock's GF Value™ is $6.84, compared to a current price of $11.09 — trading 62.1% above its estimated fair value. The current 1-Year Sharpe Ratio is -0.88. Crescent Capital BDC's overall GF Score™ is 49/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 1-Year Sharpe Ratio calculated?
1-Year Sharpe Ratio is calculated from a company's financial statements. For Crescent Capital BDC (CCAP), the current 1-Year Sharpe Ratio is -0.88 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Crescent Capital BDC (CCAP) Overvalued in 2026?

Based on GuruFocus' analysis, Crescent Capital BDC stock appears to be overvalued. The current stock price of $11.09 is trading 62.1% above its estimated GF Value™ of $6.84. GuruFocus considers Crescent Capital BDC to be Significantly Overvalued.

Key valuation signals for CCAP:

  • 1-Year Sharpe Ratio: -0.88
  • GF Value™: $6.84 vs. price of $11.09 (62.1% above fair value)
  • GF Score™: 49/100 with 4 warning signs

No single metric tells the full story. See the CCAP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Crescent Capital BDC Business Description

Other Exchanges 487:Germany
Address 11100 Santa Monica Boulevard, Suite 2000, Los Angeles, CA, USA, 90025
Crescent Capital BDC Inc is a business development company structured as an externally managed, closed-end, non-diversified management investment company. The company's primary investment objective is to maximize the total return to its stockholders in the form of current income and capital appreciation through debt and related equity investments. It will seek to achieve its investment objectives by investing in secured debt (including senior secured, unitranche, and second lien debt) and unsecured debt (including senior unsecured, mezzanine, and subordinated debt), as well as related equity securities of private U.S. middle-market companies.
49GF Score

Get the complete analysis for CCAP

1-Year Sharpe Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$11.09
Price
$6.84
GF Value